International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“Abstract submissions are still open! We’re looking forward to showcasing the research, collaboration, and innovation shaping the future of thoracic oncology across Latin America and beyond.
LALCA 2026, held in collaboration with the International Thymic Malignancy Interest Group, will bring together a global multidisciplinary community committed to advancing lung cancer care through science, education, and shared expertise.
Whether your work focuses on translational research, clinical practice, early detection, biomarkers, surgery, radiation oncology, or patient-centered care, we encourage you to submit your abstract and join the conversation.
- Share your work
- Connect with international experts
- Contribute to progress in thoracic oncology.”
Other articles about IASLC on OncoDaily.